QQ客服 官方微博 反馈留言

	The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis
	Lu Ming[1]; Zhang Jianzhong[2]; Li Ming[3]; Ge Xiaoxu[4]; Dai Xu[5]; Zhao Jiao[6]; Fu Mingzhou[7]; Wang Tao[8]; Fang Xiyao[9]; Li Can[10]
刊名	Molecular and cellular biochemistry
	2016
卷号	422页码:181-188
关键词	Angiotensin-I converting enzyme (ACE) End-stage renal disease (ESRD) Hemodialysis I/D variation Type 2 diabetes mellitus (T2DM)
ISSN号	1573-4919
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2235482
专题	上海大学
作者单位	1.Department of Endocrinology & Metabolism, Putuo Hospital Attached to Shanghai University of Traditional Chinese Medicine, 164 Lanxi Road, Shanghai, 200000, China. 2.Department of Endocrinology, China-Japan Union Hospital of Jilin University, 829 Xinmin Street, Changchun, China. 3.Department of Endocrinology & Metabolism, Shanghai Diabetes Institute, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China. 4.Shanghai Jiaotong University School of Medicine, 227 Chongqing South Road, Shanghai, 200025, China. 5.Department of Nephrology, Shanghai Diabetes Institute, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, 200233, China. 6.Division of Endocrinology, Metabolism, and Molecular Medicine, Charles R. Drew University of Medicine and Sciences, University of California Los Angeles School of Medicine, Los Angeles, CA, USA.
推荐引用方式 GB/T 7714	Lu Ming[1],Zhang Jianzhong[2],Li Ming[3],et al. The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis[J]. Molecular and cellular biochemistry,2016,422:181-188.
APA	Lu Ming[1].,Zhang Jianzhong[2].,Li Ming[3].,Ge Xiaoxu[4].,Dai Xu[5].,...&Jia Weiping[21].(2016).The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.Molecular and cellular biochemistry,422,181-188.
MLA	Lu Ming[1],et al."The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis".Molecular and cellular biochemistry 422(2016):181-188.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。